Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01443546 · ClinicalTrials.gov registry record · Phase 4
Study of Dual Trigger Ovulation in Oocyte Donors
A Phase 4 study, sponsored by Weill Medical College of Cornell University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 26
- Enrollment target
NCT01443546 is a Phase 4 study that was terminated before completion, run by Weill Medical College of Cornell University. The registered enrollment target is 26 participants.
The verdict
NCT01443546, a Phase 4 study, was terminated before completion, sponsored by Weill Medical College of Cornell University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 26 participants
- Enrollment target
Study Summary
The project is a randomized, controlled, prospective study of oocyte donors comparing the safety and efficacy of triggering ovulation using a combination of two drugs-GnRH agonist and very low dose hCG-versus triggering ovulation with a standard hCG dose alone or a standard GnRH trigger alone.
Interventions
- DRUG HCG
- DRUG Lupron Trigger
- DRUG Dual Trigger
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2013-01 |
| Est. Completion | 2016-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01443546
The ClinicalTrials.gov registry entry for NCT01443546 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which HCG is the first listed.
NCT01443546 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01443546 about?
NCT01443546 is a clinical study titled "Study of Dual Trigger Ovulation in Oocyte Donors". The project is a randomized, controlled, prospective study of oocyte donors comparing the safety and efficacy of triggering ovulation using a combination of two drugs-GnRH agonist and very low dose hCG-versus triggering ovulation with a standard hCG dose alone or a standard GnRH trigger alone.
What is the current status of trial NCT01443546?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 26 participants. The study started on 2013-01. Estimated completion is 2016-06.
What interventions are being tested in trial NCT01443546?
The interventions under investigation include: HCG (DRUG), Lupron Trigger (DRUG), Dual Trigger (DRUG).
Who is sponsoring clinical trial NCT01443546?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.